![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Provention Bio Inc | NASDAQ:PRVB | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 24.98 | 25.04 | 24.90 | 0 | 01:00:00 |
PROVENTION BIO, INC.
P.O. Box 666
Oldwick, New Jersey 08858
June 14, 2019
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: |
Provention
Bio, Inc. (the “Company”)
Request to Withdraw Registration Statement on Form S-1 (and all exhibits) (SEC File No. 333-232055) |
Ladies and Gentlemen:
Pursuant to Rule 477(a) under the Securities Act of 1933, as amended (the “Securities Act”), the Company hereby requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of the Company’s registration statement on Form S-1 (File No. 333-232055), filed with the Commission on June 10, 2019 and initially as a Draft Registration Statement on May 29, 2019 (such registration statement and all exhibits, collectively, the “Registration Statement”).
The Company is seeking withdrawal of the Registration Statement because it has determined at this time not to proceed with the transaction due to market conditions. The Company believes that withdrawal of the Registration Statement is consistent with the public interest and the protection of investors, as contemplated by Rule 477(a) under the Securities Act. Please note that the Registration Statement was not declared effective by the Commission and no securities of the Company were sold pursuant to the Registration Statement.
The Company respectfully requests, in accordance with Rule 457(p) under the Securities Act, that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the Company’s account for future use.
In accordance with Rule 477(c) under the Securities Act, the Company respectfully advises the Commission that it may undertake a subsequent private offering in reliance on Rule 155(c) under the Securities Act, following the withdrawal of the Registration Statement.
It is our understanding that this application for withdrawal of the Registration Statement will be deemed granted as of the date that it is filed with the Commission unless, within fifteen days after such date, the Company receives notice from the Commission that this application will not be granted.
If you have any questions regarding this application for withdrawal, please contact me at 732-685-4284 or our outside counsel, Steven Skolnick of Lowenstein Sander LLP, at 973-597-2476.
Very truly yours, | ||
PROVENTION BIO, INC. | ||
By: | /s/ Andrew Drechsler | |
Andrew Drechsler | ||
Chief Financial Officer |
1 Year Provention Bio Chart |
1 Month Provention Bio Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions